INVO Fertility (IVF) Competitors $0.84 +0.07 (+9.01%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IVF vs. BTCY, OSRH, SINT, CHEK, MHUA, POAI, XAIR, INBS, FEMY, and LYRAShould you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Biotricity (BTCY), OSR (OSRH), Sintx Technologies (SINT), Check-Cap (CHEK), Meihua International Medical Technologies (MHUA), Predictive Oncology (POAI), Beyond Air (XAIR), Intelligent Bio Solutions (INBS), Femasys (FEMY), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. INVO Fertility vs. Its Competitors Biotricity OSR Sintx Technologies Check-Cap Meihua International Medical Technologies Predictive Oncology Beyond Air Intelligent Bio Solutions Femasys Lyra Therapeutics INVO Fertility (NASDAQ:IVF) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability. Do insiders and institutionals hold more shares of IVF or BTCY? 12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 0.6% of INVO Fertility shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is IVF or BTCY more profitable? Biotricity has a net margin of -80.42% compared to INVO Fertility's net margin of -422.11%. Company Net Margins Return on Equity Return on Assets INVO Fertility-422.11% N/A -90.34% Biotricity -80.42%N/A -188.47% Which has more risk and volatility, IVF or BTCY? INVO Fertility has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Do analysts rate IVF or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Fertility 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher valuation and earnings, IVF or BTCY? INVO Fertility has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Fertility$6.53M0.56-$9.10M-$93.14-0.01Biotricity$12.06M1.22-$14.09M-$0.21-2.62 Does the media refer more to IVF or BTCY? In the previous week, INVO Fertility had 1 more articles in the media than Biotricity. MarketBeat recorded 1 mentions for INVO Fertility and 0 mentions for Biotricity. INVO Fertility's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score. Company Overall Sentiment INVO Fertility Neutral Biotricity Neutral SummaryINVO Fertility and Biotricity tied by winning 6 of the 12 factors compared between the two stocks. Get INVO Fertility News Delivered to You Automatically Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVF vs. The Competition Export to ExcelMetricINVO FertilitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.35M$75.67M$6.05B$10.54BDividend YieldN/AN/A5.68%4.67%P/E Ratio-0.0110.9276.3926.55Price / Sales0.5627.62582.40237.78Price / CashN/A18.4137.8961.20Price / Book-0.0116.6312.546.48Net Income-$9.10M-$26.39M$3.30B$277.02M7 Day Performance-2.44%2.14%28,086.98%1.84%1 Month Performance-9.43%8.04%30,478.96%8.29%1 Year Performance-96.56%68.15%35,729.70%36.66% INVO Fertility Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVFINVO Fertility0.1027 of 5 stars$0.84+9.0%N/A-96.9%$3.35M$6.53M-0.0110Positive NewsGap DownBTCYBiotricityN/A$0.57-6.8%N/A+157.6%$14.27M$12.06M-0.5340Gap DownOSRHOSRN/A$0.65-11.2%N/AN/A$14.10MN/A0.00N/APositive NewsShort Interest ↓SINTSintx Technologies2.548 of 5 stars$4.88+3.6%$25.00+412.3%+29.6%$13.47M$2.89M-0.1040CHEKCheck-CapN/A$2.24-8.6%N/A+74.4%$13.10MN/A-0.7580Short Interest ↑Gap DownMHUAMeihua International Medical Technologies0.6984 of 5 stars$0.40+2.1%N/A-64.0%$12.77M$96.90M0.00620Short Interest ↑POAIPredictive Oncology0.9744 of 5 stars$1.16-0.9%N/A+16.8%$12.63M$1.62M-0.3830Stock SplitShort Interest ↓XAIRBeyond Air4.1649 of 5 stars$2.31-1.7%$11.00+376.2%-59.8%$12.08M$3.70M-0.1970INBSIntelligent Bio Solutions1.3734 of 5 stars$1.32-1.9%N/A-37.0%$11.99M$3.05M-0.6410Positive NewsFEMYFemasys3.0849 of 5 stars$0.34-4.7%$7.33+2,029.3%-66.5%$11.22M$1.63M-0.4030Gap UpLYRALyra Therapeutics3.4782 of 5 stars$6.64+3.4%$100.00+1,406.0%-48.8%$10.89M$1.53M-0.2350News CoverageShort Interest ↓ Related Companies and Tools Related Companies Biotricity Competitors OSR Competitors Sintx Technologies Competitors Check-Cap Competitors Meihua International Medical Technologies Competitors Predictive Oncology Competitors Beyond Air Competitors Intelligent Bio Solutions Competitors Femasys Competitors Lyra Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVF) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmerica’s Lost StocksPorter Stansberry says the real fortunes aren’t in Tesla, Amazon, or AI — but in a handful of overlooked “lost...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.